ITRM20010336A1 - Anticorpo umano ricombinante diretto contro la proteina non strutturale ns3 del virus dell'epatite c (hcv), acido nucleico codificante e usi - Google Patents
Anticorpo umano ricombinante diretto contro la proteina non strutturale ns3 del virus dell'epatite c (hcv), acido nucleico codificante e usiInfo
- Publication number
- ITRM20010336A1 ITRM20010336A1 IT2001RM000336A ITRM20010336A ITRM20010336A1 IT RM20010336 A1 ITRM20010336 A1 IT RM20010336A1 IT 2001RM000336 A IT2001RM000336 A IT 2001RM000336A IT RM20010336 A ITRM20010336 A IT RM20010336A IT RM20010336 A1 ITRM20010336 A1 IT RM20010336A1
- Authority
- IT
- Italy
- Prior art keywords
- hcv
- human antibody
- nucleic acid
- recombinant human
- antibody against
- Prior art date
Links
- 241000711549 Hepacivirus C Species 0.000 title abstract 3
- 101800000515 Non-structural protein 3 Proteins 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 108060004795 Methyltransferase Proteins 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
- C07K16/109—Hepatitis C virus; Hepatitis G virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/028—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a herpesvirus
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2001RM000336A ITRM20010336A1 (it) | 2001-06-13 | 2001-06-13 | Anticorpo umano ricombinante diretto contro la proteina non strutturale ns3 del virus dell'epatite c (hcv), acido nucleico codificante e usi |
DK02745784T DK1417233T3 (da) | 2001-06-13 | 2002-06-11 | Humant rekombinant antistof mod det hepatitis C (HCV) ikke-strukturelle NS3-protein, nukleinsyre og anvendelser deraf |
AU2002317474A AU2002317474A1 (en) | 2001-06-13 | 2002-06-11 | Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof |
US10/480,843 US7314919B2 (en) | 2001-06-13 | 2002-06-11 | Human recombinant antibody against the hepatitis C (HCV) non structural NS3 protein nucleic acid and uses thereof |
DE60232155T DE60232155D1 (de) | 2001-06-13 | 2002-06-11 | Humaner rekombinanter antikörper gegen das hepatitis c (hcv) nichtstrukturelles ns3 protein, nukleinsäure und deren verwendungen |
AT02745784T ATE430167T1 (de) | 2001-06-13 | 2002-06-11 | Humaner rekombinanter antikörper gegen das hepatitis c (hcv) nichtstrukturelles ns3 protein, nukleinsäure und deren verwendungen |
EP02745784A EP1417233B1 (en) | 2001-06-13 | 2002-06-11 | Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof |
PCT/IT2002/000384 WO2002100900A2 (en) | 2001-06-13 | 2002-06-11 | Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2001RM000336A ITRM20010336A1 (it) | 2001-06-13 | 2001-06-13 | Anticorpo umano ricombinante diretto contro la proteina non strutturale ns3 del virus dell'epatite c (hcv), acido nucleico codificante e usi |
Publications (2)
Publication Number | Publication Date |
---|---|
ITRM20010336A0 ITRM20010336A0 (it) | 2001-06-13 |
ITRM20010336A1 true ITRM20010336A1 (it) | 2002-12-13 |
Family
ID=11455593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT2001RM000336A ITRM20010336A1 (it) | 2001-06-13 | 2001-06-13 | Anticorpo umano ricombinante diretto contro la proteina non strutturale ns3 del virus dell'epatite c (hcv), acido nucleico codificante e usi |
Country Status (8)
Country | Link |
---|---|
US (1) | US7314919B2 (it) |
EP (1) | EP1417233B1 (it) |
AT (1) | ATE430167T1 (it) |
AU (1) | AU2002317474A1 (it) |
DE (1) | DE60232155D1 (it) |
DK (1) | DK1417233T3 (it) |
IT (1) | ITRM20010336A1 (it) |
WO (1) | WO2002100900A2 (it) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2143481A1 (en) * | 2003-02-19 | 2010-01-13 | Natrix Separations Inc. | Composite materials comprising supported porous gels |
US20090136515A1 (en) * | 2005-06-02 | 2009-05-28 | Akira Matsumori | Methods of diagnosing, preventing and treating infection with Hepatitis C virus |
CA2629343A1 (en) | 2005-11-11 | 2007-05-24 | Vertex Pharmaceuticals, Inc. | Hepatitis c virus variants |
US7705138B2 (en) | 2005-11-11 | 2010-04-27 | Vertex Pharmaceuticals Incorporated | Hepatitis C virus variants |
US7858752B2 (en) * | 2006-12-05 | 2010-12-28 | Abbott Laboratories | Recombinant antibodies against hepatitis C virus and methods of obtaining and using same |
PL2125889T3 (pl) | 2007-02-21 | 2014-06-30 | Univ Massachusetts | Ludzkie przeciwciała przeciwko wirusowi żółtaczki typu C (HCV) i ich zastosowania |
EP2272862B1 (en) | 2009-07-10 | 2012-03-21 | Freie Universität Berlin | Rock2 and rock3, two new gain-of-function variants of the cytokinin receptors AHK2 and AHK3 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6194140B1 (en) * | 1990-04-04 | 2001-02-27 | Chiron Corporation | HCV NS3 protein fragments having helicase activity and improved solubility |
AU7877900A (en) * | 1999-10-13 | 2001-04-23 | Chiron Corporation | Method of obtaining cellular immune responses from proteins |
-
2001
- 2001-06-13 IT IT2001RM000336A patent/ITRM20010336A1/it unknown
-
2002
- 2002-06-11 US US10/480,843 patent/US7314919B2/en not_active Expired - Fee Related
- 2002-06-11 DE DE60232155T patent/DE60232155D1/de not_active Expired - Lifetime
- 2002-06-11 AT AT02745784T patent/ATE430167T1/de not_active IP Right Cessation
- 2002-06-11 EP EP02745784A patent/EP1417233B1/en not_active Expired - Lifetime
- 2002-06-11 WO PCT/IT2002/000384 patent/WO2002100900A2/en not_active Application Discontinuation
- 2002-06-11 AU AU2002317474A patent/AU2002317474A1/en not_active Abandoned
- 2002-06-11 DK DK02745784T patent/DK1417233T3/da active
Also Published As
Publication number | Publication date |
---|---|
ATE430167T1 (de) | 2009-05-15 |
AU2002317474A1 (en) | 2002-12-23 |
WO2002100900A2 (en) | 2002-12-19 |
EP1417233A2 (en) | 2004-05-12 |
DK1417233T3 (da) | 2009-06-29 |
EP1417233B1 (en) | 2009-04-29 |
WO2002100900A3 (en) | 2004-03-04 |
ITRM20010336A0 (it) | 2001-06-13 |
DE60232155D1 (de) | 2009-06-10 |
US20040214994A1 (en) | 2004-10-28 |
US7314919B2 (en) | 2008-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1278077B1 (it) | Metodologia per riprodurre in vitro le attivita' di rna polimerasi rna-dipendente e di nucleotidiltransferasi terminale codificate dal | |
DE69922958D1 (de) | Hcv hüllproteine partikel : verwendung für therapeutische impfung | |
SE9004010A (sv) | Viralt medel | |
EP1043399A3 (de) | Hepatitis C Virus Zellkultursystem | |
HK1092498A1 (en) | Composition containing the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors comprising corresponding nucleic sequences and the therapeutic application thereof | |
UA93349C2 (ru) | Способ стабилизации мономерного белка интерферона | |
ATE405647T1 (de) | Rekombinantes gelatin in impstoffen | |
CY1110437T1 (el) | Χρηση παραγωγων καστανοσπερμινης για την θεραπεια της ηπατιτιδας c | |
DE60330923D1 (de) | Menschliche Koagulationsfaktor VII Polypeptide | |
EA200401405A1 (ru) | Модифицированный осповакцинный вирус анкара для вакцинации новорожденных | |
WO2004085633A8 (en) | A novel human virus causing severe acute respiratory syndrome (sars) and uses thereof | |
WO2004076619A3 (en) | New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications | |
MXPA05005202A (es) | Vacuna. | |
ITRM20010336A1 (it) | Anticorpo umano ricombinante diretto contro la proteina non strutturale ns3 del virus dell'epatite c (hcv), acido nucleico codificante e usi | |
WO2001021807A8 (en) | Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof | |
ATE542140T1 (de) | Nichtstrukturelle hcv-proteinmutanten und verwendungsmöglichkeiten dafür | |
ATE556136T1 (de) | Nichtstrukturelles hcv-fusionsprotein | |
TW200509964A (en) | VP1 of foot-and-mouth disease virus | |
WO2004014936A3 (fr) | Melange de peptides issus des proteines c et ns3 du virus de l'hepatite c et leurs applications. | |
ATE403007T1 (de) | Rekombinantes mva mit der fähigkeit zur expression von hcv struktur-antigenen | |
DE69718911D1 (de) | Interleukin - 8 als antivirale- und antitumorwirkstoffe | |
SE0002498D0 (sv) | Papillomavirus vaccine | |
IT1270941B (it) | Peptidi di hcv e loro usi. | |
GB0215617D0 (en) | Use of hepatitis C virus (HCV) p7 protein | |
DE60129228D1 (de) | Humane 7-transmembranproteine und dafür codierende polynukleotide |